Spinal Cord Stimulation Global Market Report 2025

Spinal cord stimulation is a relatively recent technique designed to aid in the management of chronic pain when the underlying damage or cause cannot be remedied. This approach involves delivering electrical pulses directly into the spinal cord to regulate and control pain.

The primary types of spinal cord stimulation products are rechargeable and non-rechargeable. Rechargeable devices are those capable of being replenished with electricity. Rechargeable spinal cord stimulation is applied to address persistent neuropathic pain that persists after unsuccessful back surgery. Its applications extend to various conditions, including failed back surgery syndrome (FBSS), degenerative disc disease (DDD), complex regional pain syndrome (CRPS), arachnoiditis, among others. These products find use in different medical settings, including hospitals, ambulatory surgery centers, and specialty clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The spinal cord stimulation market research report is one of a series of new reports from The Business Research Company that provides spinal cord stimulation market statistics, including spinal cord stimulation industry global market size, regional shares, competitors with a spinal cord stimulation market share, detailed spinal cord stimulation market segments, market trends and opportunities, and any further data you may need to thrive in the spinal cord stimulation industry. This spinal cord stimulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The spinal cord stimulation market size has grown strongly in recent years. It will grow from $3.14 billion in 2024 to $3.41 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to aging population, increasing prevalence of chronic pain, rising awareness about spinal cord stimulation, and growing demand for non-invasive pain management techniques.

The spinal cord stimulation market size is expected to see strong growth in the next few years. It will grow to $4.76 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to development of innovative stimulation therapies, expanding indications for spinal cord stimulation, rising demand for minimally invasive procedures, increasing investment in research and development, reimbursement policies. Major trends in the forecast period include the integration of artificial intelligence in spinal cord stimulation devices, the emergence of non-paraesthesia-based stimulation, the focus on expanding market presence in emerging economies, the adoption of rechargeable stimulators, and emphasis on patient-centric approaches in product development.

The forecast of 8.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of advanced pain management by inflating prices of implantable neurostimulators and rechargeable battery systems developed in Switzerland and Ireland, resulting in prolonged patient suffering and higher pain clinic costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expected rise in the prevalence of spinal cord injuries is anticipated to drive the growth of the spinal cord stimulation market in the future. Spinal cord injuries encompass any damage to the spinal cord or nerves within the spinal canal, often resulting from traumatic incidents or domestic accidents. The treatment for spinal cord injuries involves spinal cord stimulation, a process that delivers low-voltage electricity to the spinal cord to alleviate pain. As of May 2022, the National Library of Medicine reported that spinal cord injuries affected between 250,000 and 500,000 individuals globally each year. In the United States alone, approximately 17,000 new spinal cord injuries are reported annually, with an estimated 282,000 Americans considered survivors of spinal cord injuries. Consequently, the growing prevalence of spinal cord injuries is serving as a catalyst for the expansion of the spinal cord stimulation market.

The rising geriatric population is anticipated to drive the growth of the spinal cord stimulation market. Individuals aged 65 and older, referred to as the geriatric population, have unique healthcare and social needs linked to the aging process. As the geriatric demographic expands, there is a substantial opportunity for the spinal cord stimulation market to grow. With an increase in chronic pain and related health issues among this age group, the demand for spinal cord stimulation solutions is expected to rise, further contributing to market expansion. For example, in October 2022, the World Health Organization, a U.S.-based specialized health agency, reported that by 2030, 1 in 6 people worldwide will be 60 years or older, with this number projected to double to 2.1 billion by 2050. Therefore, the growing geriatric population is driving the growth of the spinal cord stimulation market.

Technological innovations are a prominent trend gaining traction in the spinal cord stimulation market, with major companies focusing on advanced solutions to maintain their market positions. In December 2022, Abbott Laboratories, a US-based medical device company, introduced the Eterna spinal cord stimulation system, the smallest implantable, rechargeable spinal cord stimulator for chronic pain management currently available. Utilizing Abbott's low-dose BurstDR stimulation, the Eterna SCS has demonstrated a 23% greater relief of pain compared to conventional waveform technology methods, providing a technologically advanced solution for chronic pain treatment.

Major players in the spinal cord stimulation market are concentrating on developing innovative products, such as the Spinal Cord Stimulation System, representing a significant advancement in therapy for spinal cord stimulation. The system involves the implantation of electrodes along the spinal cord to alleviate chronic pain. In March 2023, Nevro, a US-based medical device company specializing in chronic pain treatment, launched the Revolutionary HFX iQ Spinal Cord Stimulation System. Distinguished by its use of artificial intelligence, the system offers personalized pain relief through real-time adjustments based on extensive clinical data. Featuring the HFX algorithm and comprehensive pain management, this system not only represents a significant advancement in spinal cord stimulation therapy but also contributes to the market by offering innovative, data-backed, and AI-powered solutions for individuals with chronic pain.

In November 2023, Nevro, a US-based medical device company for chronic pain, completed the acquisition of VYRSA Technologies for an upfront payment of $40 million and an additional $35 million in milestone payments. This acquisition is notable in the spinal cord stimulation market, diversifying Nevro's product offering, expanding its portfolio and market reach, and addressing unmet medical needs in chronic pain treatment. VYRSA Technologies is a US-based medical technology company with a focus on sacroiliac joint fusion.

Major companies operating in the spinal cord stimulation market include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Boston Scientific Corp., LivaNova PLC, Globus Medical Inc., ZimVie Inc., Avanos Medical Inc. , Nevro Corp., Axonics Modulation Technologies Inc., SPR Therapeutics Inc., BlueWind Medical, Bioness Inc., Saluda Medical Pty. Ltd., Soterix Medical Inc., Synapse Biomedical Inc., NeuroMetrix Inc., NDI Medical LLC, Neuros Medical Inc., Cirtec Medical Corp., Mainstay Medical International plc, Gimer Medical

North America was the largest region in the spinal cord stimulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spinal cord stimulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the spinal cord stimulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The spinal cord stimulation market consists of sales of neurostimulators, leads, extensions, and handheld controllers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spinal Cord Stimulation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on spinal cord stimulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for spinal cord stimulation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spinal cord stimulation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Rechargeable; Non-rechargeable
• 2) By Application: Failed Back Surgery Syndrome (FBSS); Degenerative Disc Disease (DDD); Complex Regional Pain Syndrome (CRPS); Arachnoiditis; Other Disease Indications
• 3) By End User: Hospitals; Ambulatory Surgery Centers; Specialty Clinics
• Subsegments:
• 1) By Rechargeable: Implantable Pulse Generators (IPGs); Rechargeable Lead Systems
• 2) By Non-Rechargeable: Non-Rechargeable Implantable Pulse Generators (IPGs); Non-Rechargeable Lead Systems
• Companies Mentioned: Abbott Laboratories; Medtronic PLC; Stryker Corporation; Boston Scientific Corp.; LivaNova PLC; Globus Medical Inc.; ZimVie Inc.; Avanos Medical Inc. ; Nevro Corp.; Axonics Modulation Technologies Inc.; SPR Therapeutics Inc.; BlueWind Medical; Bioness Inc.; Saluda Medical Pty. Ltd.; Soterix Medical Inc.; Synapse Biomedical Inc.; NeuroMetrix Inc.; NDI Medical LLC; Neuros Medical Inc.; Cirtec Medical Corp.; Mainstay Medical International plc; Gimer Medical
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.